PT-141

PT-141 (Bremelanotide) is a synthetic cyclic melanocortin receptor agonist that binds MC3R and MC4R in the CNS. Unlike PDE5 inhibitors, it operates through central melanocortin receptor pathways rather than vascular mechanisms. Research covers CNS melanocortin signaling and receptor pharmacology. Supplied as lyophilized powder for research use only.

Research Use Only. All products sold on this website are strictly for laboratory research, in-vitro testing, and analytical purposes only. Products are not intended for human consumption, diagnostic, therapeutic, or any medical applications. Not evaluated or approved by the FDA.